Fresenius pounces on bank appetite for €1.6bn delayed draw
German healthcare group Fresenius (Ba1/BB+/BB+) is seeking to take advantage of what it sees as "favourable financing conditions" in the bank market to refinance its term loan ‘A’ and revolving credit facility due in September 2013.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
